New business growth is increasingly found in the emerging markets throughout Asia, Africa and Latin America. These "Pharmerging" markets are growing 3-5 times that of established markets. Supplying patients in these areas puts major new requirements on pharmaceutical companies and their supply partners to ensure market access and cost-effectively extend their supply capabilities.
It is also critical to reach directly to the patient and provider population to ensure brand awareness and support regimen compliance. With counterfeiting levels reaching 10-30+% in these markets and supply chains that are often immature in development, providing safeguards directly to patients is also paramount.
TraceLink's global network platform coupled with mobile device support delivers an "always-on" communication service that patients and providers can leverage to protect safety and enable health.